BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19076153)

  • 1. A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.
    Becker ML; Visser LE; Newton-Cheh C; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Br J Clin Pharmacol; 2009 Jan; 67(1):61-7. PubMed ID: 19076153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea.
    Becker ML; Aarnoudse AJ; Newton-Cheh C; Hofman A; Witteman JC; Uitterlinden AG; Visser LE; Stricker BH
    Pharmacogenet Genomics; 2008 Jul; 18(7):591-7. PubMed ID: 18551039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation.
    van Noord C; Aarnoudse AJ; Eijgelsheim M; Sturkenboom MC; Straus SM; Hofman A; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2009 Apr; 19(4):260-6. PubMed ID: 19247217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NOS1AP gene rs10494366 common genetic variant does not modify the risk of sudden cardiac death in users of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Stricker BH; Ahmadizar F
    Br J Clin Pharmacol; 2024 May; ():. PubMed ID: 38822495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia.
    Esen-Sehir D; Kopf J; Hägele S; Plichta MM; Reif A; Freudenberg F
    Pharmacopsychiatry; 2022 Sep; 55(5):266-273. PubMed ID: 35732169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
    Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
    BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
    Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
    Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
    Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences.
    Meredith PA; Elliott HL
    J Hypertens; 2004 Sep; 22(9):1641-8. PubMed ID: 15311086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
    Arioka I; Dohi S; Dohi S; Sakai K
    Arzneimittelforschung; 2008; 58(9):435-40. PubMed ID: 18972872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic variant of NOS1AP effects on cardiac alternans of repolarization during exercise testing.
    Koskela J; Kähönen M; Nieminen T; Lehtinen R; Viik J; Nikus K; Niemelä K; Kööbi T; Tobin MD; Samani NJ; Turjanmaa V; Pörsti I; Lehtimäki T
    Scand J Clin Lab Invest; 2012 Apr; 72(2):100-7. PubMed ID: 22133205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Meta-Analysis of the Association Between a Common NOS1AP Genetic Polymorphism, the QTc Interval, and Sudden Death.
    Zang X; Li S; Zhao Y; Chen K; Wang X; Song W; Ma J; Tu X; Xia Y; Zhang S; Gao C
    Int Heart J; 2019 Sep; 60(5):1083-1090. PubMed ID: 31447468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study.
    Eijgelsheim M; Newton-Cheh C; Aarnoudse AL; van Noord C; Witteman JC; Hofman A; Uitterlinden AG; Stricker BH
    Hum Mol Genet; 2009 Nov; 18(21):4213-8. PubMed ID: 19643915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of calcium channel blockers and myocardial infarction in hypertensive patients with rheumatoid arthritis - A nationwide cohort study.
    Lin TT; Ko TY; Lin LY; Wu CK
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):350-358. PubMed ID: 31257076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-atherosclerotic potential of dihydropyridine calcium channel blockers.
    Ishii N; Matsumura T; Shimoda S; Araki E
    J Atheroscler Thromb; 2012; 19(8):693-704. PubMed ID: 22653165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.